Obesity and Its Nurturing Effect on Hepatitis C

This publication has 15 references indexed in Scilit:

• High Body Mass Index Is An Independent Risk Factor for Nonresponse to Antiviral Treatment in Chronic Hepatitis C
  Hepatology, 2003
• Contribution of obesity to hepatitis C-related fibrosis progression
  American Journal of Gastroenterology, 2002
• Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C
  Gut, 2002
• Lower Th-1/Th-2 Ratio Before Interferon Therapy May Favor Long-Term Virological Responses in Patients with Chronic Hepatitis C
  Digestive Diseases and Sciences, 2002
• Steatosis Accelerates the Progression of Liver Damage of Chronic Hepatitis C Patients and Correlates With Specific Hcv Genotype and Visceral Obesity
  Hepatology, 2001
• Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
  New England Journal of Medicine, 2000
• Body Composition and Hepatic Steatosis As Precursors for Fibrotic Liver Disease
  Hepatology, 1999
• Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and Steatosis
  Hepatology, 1999
• Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis
  Hepatology, 1995
• Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.
  Gut, 1993